Extrawell Pharmaceutical Holdings Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Extrawell Pharmaceutical Holdings Limited with three other
drug stores in Asia:
Hong Kong Life Sciences and Technologies Group Ltd
sales of 123.37 million Hong Kong Dollars [US$15.90 million]
of which 77%
was Trading Business),
Hin Sang Group International Holding Co Ltd
(227.46 million Hong Kong Dollars [US$29.32 million]
of which 81%
was Product Development Segment), and
Ibl Healthcare Limited
based in Pakistan
(1.16 billion Pakistan Rupees [US$11.04 million]
During the year ended March of 2016, sales at
Extrawell Pharmaceutical Holdings Limited were HK$142.20 million (US$18.33 million).
increase of 10.4%
versus 2015, when the company's sales were HK$128.83 million.
Despite this increase, sales are still
below the level achieved in 2014, when Extrawell Pharmaceutical Holdings Limited
reported sales of HK$150.67 million.
Sales of Manufacturing saw an increase
15.0% in 2016, from
HK$37.29 million to HK$42.89 million.